49
Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 Day 3, 2020 P 2 SAC Fall Conference 1

Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Clearing the AirRethinking Dust Safety in Pharmaceutical Manufacturing

Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis

10Dec2020 – Day 3, 2020 P2SAC Fall Conference1

Page 2: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

2

Research Directions

Continuous Manufacturing Safety Dilemma

Creating a Probabilistic Model

Pharma → Pharmaceutical Powder Processing

Presentation Deliverables

Photo credit: flcyc.org

Page 3: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Presentation Flow

Credit: China Daily

Credit: China Underground

Credit: Time Magazine

Credit: Callidus Health and Safety

Dusts in the Workplace

3

Page 4: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Presentation Flow

Credit: Callidus Health and Safety

Credit: China Daily

Credit: China Underground

Credit: Time Magazine

Credit: Chemical &Engineering News

Credit: China Daily

Dusts in the Workplace

Credit: Engineering News-Record 4

Page 5: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

6 killed, 38 injured

credit: CSB

West Pharmaceuticals, 2003

5

• Clean Facility

• Unidentified Cause

• Operated “Safely” for Years

Page 6: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Dust Safety in Pharma

6

Is it safe?

Page 7: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Credit: Fortune.com

Bunny Suits and Enclosures: Responding to personnel exposure risks

“Continuous processes are inherently safer” 7

Page 8: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

The Continuous Manufacturing Dilemma

Containment Measures

ConfinementPersonnel

Exposure

Isolation helps with personnel exposure,

but worsens explosion hazards.

Batch Process

Equivalent Continuous Process

8

Page 9: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

More Continuous Manufacturing Dilemma

Pneumatic Conveying

DispersionPersonnel

Exposure

Continuous manufacturing promotes dust

dispersing methods like pneumatic conveying.

credit: https://www.powderbulksolids.com/pneumatic-conveying/contained-powder-transfer-vacuum-based-pneumatic-conveying

9

Page 10: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Even More Continuous Manufacturing Dilemma

Remote Operation

Hazard

Impact

Personnel

Exposure

With minimal personnel supervision, fault

detection becomes an even bigger issue.

10

Page 11: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Pharma manufacturing

is NOT inherently safe

No high-profile

incidents on

combustible dusts

Dust deflagration

and explosion

can still occur

BUT YET

11

Page 12: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Quantifying RiskMaking the best safety decision

12

Page 13: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Risk-based DHAAIChE 2017, CCPS Guidelines for Combustible Dust Hazards Analysis

Discipline on

thought process,

flexibility in

application.

13

Risk = f(consequence, likelihood)

Page 14: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

14

Credit: Prasad Goteti, Honeywell

Page 15: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Risk = f(severity, likelihood)

Risk = Probability (event)

Likelihood → Frequency of events

Dust Explosion Risk = Probability (explosion)

Dust Exposure Risk = Probability (exposure)

Page 16: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Risk-based DHA allows for the design of a completely safe facility.

But…

Equipment parts break down. Systems fail.

How do you manage these abnormal events?

Unexpected things happen. Faults happen.

16

Page 17: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

17Credit: Prasad Goteti, Honeywell

Page 18: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Summary so far…

18

Continuous manufacturing dilemmaPersonnel exposure vs dust explosion

Real-time failure detection is criticalPlan for parts to fail

Quantify risk

Bayesian probabilityProbabilistic Model

Condition Monitoring

Page 19: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Modeling Using Factor Graphs

Probabilistic Condition Monitoring

Process

Knowledge

Equipment and

Process Data

Probabilistic Model

Safety Questions Will there be an explosion?

How likely is an explosion?

AnswersThere will be an explosion?

The probability of an explosion is 75%.

19A Probabilistic Graphical Model (PGM)

Page 20: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

20

PGM: A Representation of Knowledge

Given the observations from two sensors,

what is the probability that the process is

faulty?

A = Process is Faulty

B = Sensor 1 is Faulty

C = Sensor 1 Readings

D = Sensor 2 Readings

E = Sensor 2 is Faulty

Inference

P(A|C,D)

P(B|C)

Given observations via sensor

measurements, what is the probability that

the sensor is faulty?

Y

Z Observed, Continuous Variables

Hidden, Continuous Variables

X Hidden, Discrete Variables

A B

C

E

D

Page 21: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Bayes Network

21

A

C

B E

D

FactorsFunctions/Tables that mathematically represent priors, relationships

Factor GraphBern (0.10) Bern (0.05) Bern (0.05)

C D

A B E

Y

Z Observed, Continuous Variables

Hidden, Continuous Variables

X Hidden, Discrete Variables

𝑪 = 𝑮𝒂𝒖𝒔𝒔(𝒘𝟎+𝒘𝟏𝑨𝟏+𝒘𝟐𝑩𝟐,𝝈𝒄𝟐)

Types of Probabilistic Graphical Models (PGM)

Page 22: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

22

Purdue University Continuous Tablet (OSD Form) Manufacturing Pilot Plant

Loss-in-Weight Feeders Tablet Press

Roller Compactor

Blender Blender

Powder Granule Tablet

Page 23: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day
Page 24: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

25

Implementing the ModelT. Minka, J. Winn, J. Guiver, Y. Zaykov, D. Fabian, and J. BronskillInfer.NET 0.3, Microsoft Research Cambridge, 2018.http://dotnet.github.io/infer

Page 25: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Feed

Screw

Speed

Roll

Gap

Roll

Pressure

Roll

Speed

Training Data – Normal Condition

27

Gupta, A., Giridhar, A., Venkatasubramanian, V., & Reklaitis, G. V. (2013).

Intelligent alarm management applied to continuous pharmaceutical tablet manufacturing: an integrated approach. Industrial & Engineering

Chemistry Research, 52(35), 12357-12368.

Simulated Data based on Previous Study:

Page 26: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Training Data: Fault 1 Induced at 100s

28

Feed

Screw

Speed

Roll

Gap

Roll

Pressure

Roll

Speed

Can the system

detect fault 1?

Fault 1 – Feeder Blockage

Page 27: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Yes it can!

29

Prob(Condition = Normal)

Prob(Condition = Fault1)

seconds

Fault 1 Induced at t = 100s

Page 28: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Unknown Fault? Fault 2 Induced at 100s

30

Model untrained for the fault 2 – Controller Malfunction

Can the system

differentiate this from

Normal Condition and

Fault 1?

Feed

Screw

Speed

Roll

Gap

Roll

Pressure

Roll

Speed

Page 29: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

It can detect novel faults!

31

System is “less certain” of its prediction

P(Condition = Normal)

P(Condition = Fault1)

Detect new faults or

conditions based on

certainty of prediction.

seconds

P(Condition)

Page 30: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Training Model with Fault2: Fault 2 Induced at 100s

32

Increased Certainty about Predictions of Condition

seconds

P(Condition)

P(Normal)

P(Fault1)

P(Fault2) Added Fault 2 as variable

to the model.

Page 31: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Training Model with Fault2: Fault 1 Induced at 100s

33

Fault 1 was still properly assessed

seconds

P(Condition)

P(Normal)

P(Fault1)

P(Fault2)

Added Fault 2 as variable

to the model.

Capabilities:

Detect and Diagnose Known Faults

Detect Novel Faults

Store New Faults

Fault Management

Fault Repository

Page 32: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Developing a Probabilistic Model for Dust Safety

34

For Condition Monitoring

Page 33: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Assign Random Variables: Safety Questions

35

P(explosion)

P(exposure)

P(normal)

1 facility will explode

0 otherwise

1 dangerous exposure if person is present in facility

0 otherwise

1 normal/safe

0 otherwise

Page 34: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Assign Random Variables: Using Data to Answer Safety Questions

36

P(explosion) P(exposure) P(normal)

ScoreExplosion ScoreExposure ScoreExposure

Data

Page 35: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Adding Factor Nodes: Dust Explosion Data

37

P(explosion)

ScoreExplosion

Data PSD

PR

Kst

MEC

MIE

MAIT

LIT

O2 conc.

LOC

Humidity

Temp.

Resistivity

Volume

Throughput

Page 36: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Adding Factor Nodes: Dust Explosion Score Parameters

38

P(explosion)

ScoreExplosion

PSD O2 conc.HumidityTemp.

x𝑺𝒄𝒐𝒓𝒆 = 𝒘𝟎+𝒘𝒊𝑺𝒊

w0

w1

w2

w3

w4

Page 37: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Adding Factor Nodes: Continuous to Discrete Variable

39

P(explosion)

ScoreExplosion

PSD O2 conc.HumidityTemp.

x

w0

w1

w2

w3

w4

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

𝑺𝒄𝒐𝒓𝒆 = 𝒘𝟎+𝒘𝒊𝑺𝒊

Page 38: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

# Data Streams

Condensed Representation

40

P(explosion)

ScoreExplosion

PSDO2 conc.Humidity

x wi

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

Datai

Page 39: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

# Data Streams

Repeating Structure for Other Events

41

P(explosion)

ScoreExplosion

PSDO2 conc.Humidity

x wi

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

Datai

# Data Streams

P(exposure)

ScoreExposure

PSDO2 conc.Humidity

x vi

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

Datai

Page 40: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Even More Condensed Structure

42

P(explosion)

ScoreExplosion

x

wi

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

# Data Streams

P(exposure)

ScoreExposure

x

vi

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

Datai

Page 41: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Even More Condensed Structure

43

P(event)

ScoreEvent

xwi

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

# Data Streams

Datai

# Events

Event = {Normal, Explosion, Exposure}

Page 42: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Next Steps: Dispersion-related Data

44

PSD

PR

Kst

MEC

MIE

MAIT

LIT

O2 conc.

LOC

Humidity

Temp.

Resistivity

Volume

Throughput

Page 43: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Opportunities for Research

Novel Sensors for Monitoring Dispersion

Measure dust concentration in the air.

Collaboration with Professor Ambrose.

Smartphone into regular camera.

Integrate into fault detection system.

https://www.innopharmatechnology.com/products/eyecon2tm

Eyecon2

Particle Size Analyzer:

D10, D25, D50, D75, D90 in real time

45

PSD

Measure particle size distribution.

Page 44: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Next Steps: Training the Model

46

Impractical to induce deflagrations

# Data Streams

P(explosion)

ScoreExplosion

PSDO2 conc.Humidity

x wi

> threshold

𝐺𝑎𝑢𝑠𝑠𝑖𝑎𝑛(0,1)

Datai

CFD Simulations are necessary

Page 45: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Opportunities for Research

Simulation1. What is the critical enclosure volume

and geometry for each operation

mode?

2. Is there a critical size distribution to

keep a powder processing facility safe?

CFD SimulationZhao, Y., & Ambrose, R. K. (2019).

Modeling dust dispersion and suspension pattern under turbulence. Journal of Loss Prevention in the Process Industries, 62,

103934.

47

Page 46: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Opportunities for Research

CFD Simulation and Probabilistic Modeling

What is the critical enclosure volume and

geometry for each operation mode?

Batch Process

Equivalent Continuous Process

Is there a critical size distribution to keep a powder

processing facility safe?

48

Page 47: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Conclusion● Showed the advantages of a Probabilistic Condition Monitoring Model for a Roller Compactor.

● Demonstrated the use of Factor Graphs to create a Dust Safety Monitoring Model for a Pharmaceutical

Powder Processing Facility.

● Discussed research opportunities that are essential for the development of the model:

○ Development and Testing of Novel Sensors: Dust Concentration (Regular Camera), Particle Size

Distribution (Eyecon2)

○ CFD Simulations: Produce Training Data for the Probabilistic Condition Monitoring Model, Batch vs

Continuous Mode Confinement Dilemma, Critical Particle Size Distribution Determination.

Future Work

● Train and improve the Probabilistic Condition Monitoring Model.

● Determine feasibility of novel sensors for condition monitoring: Regular Camera and Eyecon2

49

Ideas for your Safety Problem

Page 48: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

50

Page 49: Clearing the Air · 2020. 12. 18. · Clearing the Air Rethinking Dust Safety in Pharmaceutical Manufacturing Rexonni B. Lagare, Zoltan Nagy, Gintaras V. Reklaitis 10Dec2020 –Day

Thank you for your attention.

51

Any questions?

Email: [email protected], [email protected]